Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LOXL2 | Q9Y4K0 | 19/20 | 0.42 |
| ▸ | DAO | P14920 | 2/20 | 0.37 |
| ▸ | AOC3 | Q16853 | 2/20 | 0.37 |
| ▸ | LOX | P28300 | 2/20 | 0.36 |
| ▸ | LOXL3 | P58215 | 2/20 | 0.36 |
| ▸ | LOXL1 | Q08397 | 2/20 | 0.36 |
| ▸ | LOXL4 | Q96JB6 | 2/20 | 0.36 |
| ▸ | PTGDR2 | Q9Y5Y4 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20915555 | 0.90 | LOXL2 (0.46) | LOXL2DAOAOC3LOXLOXL3 | |
| SCHEMBL20915553 | 0.90 | LOXL2 (0.46) | LOXL2DAOAOC3LOXLOXL3 | |
| SCHEMBL19249683 | 0.87 | PTGDR2 (0.34) | PTGDR2 | |
| SCHEMBL20915620 | 0.86 | LOXL2 (0.51) | LOXL2DAOAOC3LOXLOXL3 | |
| SCHEMBL29594898 | 0.86 | LOXL2 (0.51) | LOXL2DAOAOC3LOXLOXL3 | |
| SCHEMBL19249482 | 0.86 | LOXL2 (0.51) | LOXL2DAOAOC3LOXLOXL3 | |
| SCHEMBL19249679 | 0.86 | LOXL2 (0.49) | LOXL2DAOAOC3LOXLOXL3 | |
| SCHEMBL29594701 | 0.85 | LOXL2 (0.46) | LOXL2DAOAOC3LOXLOXL3 | |
| SCHEMBL19249485 | 0.85 | LOXL2 (0.51) | LOXL2DAOAOC3LOXLOXL3 | |
| SCHEMBL19249639 | 0.85 | LOXL2 (0.46) | LOXL2DAOAOC3LOXLOXL3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109153642-B | Indole and azaindole halogenated allylamine derivative inhibitors of lysyl oxidase and uses thereof | 法玛西斯有限公司 | 2022-05-17 | — | — | CN | disclosed |
| US-10717734-B2 | Indole and azaindole haloallylamine derivative inhibitors of lysyl oxidases and uses thereof | PHARMAXIS LTD. (AU) | 2020-07-21 | — | — | US | disclosed |
| US-20190119269-A1 | INDOLE AND AZAINDOLE HALOALLYLAMINE DERIVATIVE INHIBITORS OF LYSYL OXIDASES AND USES THEREOF | PHARMAXIS LTD. (AU) | 2019-04-25 | — | — | US | disclosed |
| WO-2017136871-A9 | INDOLE AND AZAINDOLE HALOALLYLAMINE DERIVATIVE INHIBITORS OF LYSYL OXIDASES AND USES THEREOF | PHARMAXIS LTD. (AU) | 2018-02-15 | — | — | WO | disclosed |
| WO-2017136871-A1 | INDOLE AND AZAINDOLE HALOALLYLAMINE DERIVATIVE INHIBITORS OF LYSYL OXIDASES AND USES THEREOF | PHARMAXIS LTD. (AU) | 2017-08-17 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10717734-B2 | Indole and azaindole haloallylamine derivative inhibitors of lysyl oxidases and uses thereof | IDO1, IDO2, INMT | LOXL2 23/4885DAO 5/4885AOC3 27/4885 |
| US-20190119269-A1 | INDOLE AND AZAINDOLE HALOALLYLAMINE DERIVATIVE INHIBITORS OF LYSYL OXIDASES AND USES THEREOF | IDO1, IDO2, INMT | LOXL2 23/4885DAO 5/4885AOC3 27/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.